Homre schedules AGM to approve ₹12.5 crore warrant issue

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Homre schedules AGM for September 24, 2026, to approve ₹12.5 crore FCW issue
  • Standalone revenue jumps to ₹15.28 crore in FY26 from nil previously
  • Consolidated net loss of ₹23.69 lakh driven by ₹1.24 crore deferred tax charge
  • Board reshuffle includes regularization of MD Sandeep Dewan and Chairperson Sheetal Jain
  • Company adopts ESOP plan granting up to 3 crore options to employees
powered bylight_fuzz_icon
49817934

*this image is generated using AI for illustrative purposes only.

Homre has scheduled its 36th Annual General Meeting for September 24, 2026, to seek shareholder approval for a preferential issue of fully convertible warrants worth ₹12.5 crore. The meeting will also address significant changes to the Board of Directors and the adoption of an Employee Stock Option Plan.

The company plans to issue 5,41,12,553 Fully Convertible Warrants at ₹2.31 per warrant to eight allottees, including promoter entity Supriya Securities Pvt. Ltd. and non-promoter Ganpati Warehousing Limited. Each warrant will be convertible into one equity share within 18 months of allotment.

Financial Performance

For the financial year ended March 31, 2026, Homre reported standalone revenue from operations of ₹15.28 crore, rising from nil in the previous year. This growth was driven by the commencement of commercial operations in biomass briquettes, pellets, and non-ferrous metals trading.

Metric FY26 FY25 Change
Revenue ₹15.28 crore Nil New Operations
Net Profit ₹1.19 crore ₹0.08 crore Up 13x
EPS ₹0.059 ₹0.004 Up 1375%

On a consolidated basis, however, the group recorded a net loss of ₹23.69 lakh due to a deferred tax charge of ₹1.24 crore attributable to its subsidiary, Maple e-Solutions Limited. The subsidiary itself reported a loss after tax of ₹1.21 crore for the year.

What the Numbers Show

The divergence between standalone profitability and consolidated losses highlights the impact of the subsidiary's tax position on the group's bottom line. While Homre generated ₹1.19 crore in standalone profit, the consolidated deferred tax expense of ₹1.24 crore—primarily linked to Maple e-Solutions—turned the group result negative. This suggests that future group profitability will depend heavily on resolving the subsidiary's tax asset/liability positions alongside scaling core operations.

Corporate Actions

Shareholders will vote on several special resolutions:

  • Preferential Issue: Approval for the issuance of FCWs aggregating ₹12.5 crore.
  • ESOP Plan: Adoption of the Homre Employee Stock Option Plan – 2026, granting up to 3 crore options to eligible employees and directors.
  • Board Changes: Regularization of Sandeep Dewan as Managing Director and Sheetal Jain as Chairperson. Several directors, including Rohit Inder Himatsingani and Abhishek Bhagwat Bharad, will see their designations changed to Independent Non-Executive Directors.

The company has not recommended any dividend for FY26, proposing instead to carry forward profits to retained earnings to fund working capital and expansion plans. The Bharatpur plant in Rajasthan is now in the operational readiness phase.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
-4.90%0.0%-8.92%+57.72%0.0%0.0%

How will the conversion of ₹12.5 crore in fully convertible warrants within 18 months impact Homre's equity dilution and promoter holding percentages?

What specific strategies does management have to resolve the deferred tax liabilities at Maple e-Solutions to align consolidated profitability with standalone performance?

Will the operational readiness of the Bharatpur plant in Rajasthan be accelerated by the capital raised through the preferential issue, and what is the expected revenue contribution timeline?

Homre Ltd sets ₹2.31 floor price for preferential FCW issue

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Homre Limited set the floor price for its preferential FCW issue at ₹2.31 per warrant
  • The company proposes to allot 5,41,12,553 fully convertible warrants
  • Aggregate consideration from the issue amounts to approximately ₹12.50 crore
  • Each warrant is convertible into one equity share with a face value of ₹1
powered bylight_fuzz_icon
49296684

*this image is generated using AI for illustrative purposes only.

Homre Limited has determined the floor price for its proposed preferential issue of fully convertible warrants (FCWs) at ₹2.31 per warrant. The company announced the pricing on August 26, 2026, citing August 25, 2026, as the relevant date for valuation under SEBI ICDR Regulations.

The issue aims to raise aggregate consideration of approximately ₹12.50 crore. The company plans to allot 5,41,12,553 FCWs on a preferential basis. Each warrant carries a face value of ₹1 and is convertible into one equity share of the same face value.

Issue Details

The pricing mechanism adheres to the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018. The floor price serves as the minimum issue price; the actual allotment price will not be lower than this threshold.

Metric Value
Floor Price ₹2.31 per warrant
Number of Warrants 5,41,12,553
Aggregate Consideration ₹12,49,99,997
Conversion Ratio 1:1 (Equity Share)
Relevant Date August 25, 2026

Regulatory Compliance

The intimation was issued to BSE Limited by Bharat Singh Bisht, Whole-Time Director. The proposal is subject to necessary statutory, regulatory, and other approvals before finalization. The company previously operated under the name Triton Corp Limited.

Historical Stock Returns for HOMRE

1 Day5 Days1 Month6 Months1 Year5 Years
-4.90%0.0%-8.92%+57.72%0.0%0.0%

What is the intended use of the ₹12.50 crore raised through this preferential issue, and how will it impact Homre Limited's operational expansion or debt reduction?

How might the conversion of 5.41 crore warrants into equity shares affect existing shareholders' dilution and the company's earnings per share (EPS) in the long term?

Given the floor price of ₹2.31, what market conditions or investor sentiment factors could influence the final allotment price if it exceeds this threshold?

More News on HOMRE

1 Year Returns:0.00%